These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 1565570)
1. [L-18F-dopa-PET in Parkinson-plus syndromes for the detection of a disordered presynaptic dopaminergic function]. Cordes M; Snow BJ; Takahashi H; Schofield P; Cooper S; Sossi V; Morrison S; Calne DB Nuklearmedizin; 1992 Mar; 31(2):43-7. PubMed ID: 1565570 [TBL] [Abstract][Full Text] [Related]
2. [Presynaptic nigrostriatal function in Parkinson disease and Parkinson-plus syndromes. Comparative studies using positron emission tomography with L-6-(18F)fluorodopa]. Cordes M; Poewe W Nervenarzt; 1994 Oct; 65(10):696-9. PubMed ID: 7808568 [TBL] [Abstract][Full Text] [Related]
3. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742 [TBL] [Abstract][Full Text] [Related]
4. Nigrofrontal dopaminergic function as assessed by 18F-dopa PET. Otsuka M; Ichiya Y; Kuwabara Y; Sasaki M; Yoshida T; Fukumura T; Masuda K Nucl Med Commun; 1995 Dec; 16(12):1021-5. PubMed ID: 8719983 [TBL] [Abstract][Full Text] [Related]
5. Parametric imaging of the rate constant Ki using [18Fluoro]-L-dopa positron emission tomography in progressive supranuclear palsy. Cordes M; Snow BJ; Morrison S; Sossi V; Ruth TJ; Calne DB Neuroradiology; 1993; 35(6):404-9. PubMed ID: 8377907 [TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography in Shy-Drager syndrome. Bhatt MH; Snow BJ; Martin WR; Cooper S; Calne DB Ann Neurol; 1990 Jul; 28(1):101-3. PubMed ID: 2375624 [TBL] [Abstract][Full Text] [Related]
7. Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study. Ito K; Nagano-Saito A; Kato T; Arahata Y; Nakamura A; Kawasumi Y; Hatano K; Abe Y; Yamada T; Kachi T; Brooks DJ Brain; 2002 Jun; 125(Pt 6):1358-65. PubMed ID: 12023324 [TBL] [Abstract][Full Text] [Related]
8. [Functional imaging for disorders of basal ganglia]. Otsuka M; Taniwaki T Rinsho Shinkeigaku; 1999 Jan; 39(1):30-2. PubMed ID: 10377793 [TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography in progressive supranuclear palsy. Bhatt MH; Snow BJ; Martin WR; Peppard R; Calne DB Arch Neurol; 1991 Apr; 48(4):389-91. PubMed ID: 1901484 [TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slow. Bhatt MH; Snow BJ; Martin WR; Pate BD; Ruth TJ; Calne DB Ann Neurol; 1991 Jun; 29(6):673-7. PubMed ID: 1892369 [TBL] [Abstract][Full Text] [Related]
12. Sympathetic cardioneuropathy in dysautonomias. Goldstein DS; Holmes C; Cannon RO; Eisenhofer G; Kopin IJ N Engl J Med; 1997 Mar; 336(10):696-702. PubMed ID: 9041100 [TBL] [Abstract][Full Text] [Related]
13. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Brooks DJ; Ibanez V; Sawle GV; Playford ED; Quinn N; Mathias CJ; Lees AJ; Marsden CD; Bannister R; Frackowiak RS Ann Neurol; 1992 Feb; 31(2):184-92. PubMed ID: 1575457 [TBL] [Abstract][Full Text] [Related]
14. PET studies on the early and differential diagnosis of Parkinson's disease. Brooks DJ Neurology; 1993 Dec; 43(12 Suppl 6):S6-16. PubMed ID: 8264913 [TBL] [Abstract][Full Text] [Related]